A. Collier Smyth
Geen lopende functies
Profiel
A.
Collier Smyth is the founder of New Hampshire Oncology-Hematology PA, which was founded in 1976.
Smyth held the title of President at the company.
Smyth's former jobs include Director at ARIAD Pharmaceuticals, Inc. from 2009 to 2011, Independent Director at EpiCept Corp.
from 2011 to 2012, Senior Vice President-Medical Strategy at Bristol Myers Squibb Co. in 2009, and Vice President-Medical Affairs at US Oncology, Inc. Smyth received a doctorate degree from The Johns Hopkins University and an undergraduate degree from Lehigh University.
Eerdere bekende functies van A. Collier Smyth
Bedrijven | Functie | Einde |
---|---|---|
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Directeur/Bestuurslid | 28-08-2012 |
ARIAD PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 28-04-2011 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-03-2009 |
New Hampshire Oncology-Hematology PA
New Hampshire Oncology-Hematology PA Hospital/Nursing ManagementHealth Services New Hampshire Oncology-Hematology PA provides healthcare survives. The company was founded by Collier A. Smyth in 1976 and is headquartered in Hooksett, NH. | Oprichter | - |
US Oncology, Inc.
US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van A. Collier Smyth
The Johns Hopkins University | Doctorate Degree |
Lehigh University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
US Oncology, Inc.
US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Health Services |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
New Hampshire Oncology-Hematology PA
New Hampshire Oncology-Hematology PA Hospital/Nursing ManagementHealth Services New Hampshire Oncology-Hematology PA provides healthcare survives. The company was founded by Collier A. Smyth in 1976 and is headquartered in Hooksett, NH. | Health Services |